Tirzepatide is a prescription weight loss medication with clinical results that have outperformed every other option in its class. At ThinMD MedSpa, Dr. Anthony Capasso MD prescribes and supervises tirzepatide therapy for patients in Jacksonville and Jacksonville Beach who want medically guided weight loss, not a diet plan, not a supplement, not a program built around willpower.
Tirzepatide is a weekly injectable medication that works through two distinct mechanisms simultaneously. It activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual-action approach sets it apart from every other medication in this category.
GLP-1 receptor agonists, like semaglutide, slow gastric emptying, reduce appetite, and improve insulin response. Tirzepatide does all of that and also activates GIP receptors, which further improves how the body processes glucose and stores fat. In the SURMOUNT-1 trial, participants on tirzepatide lost an average of 22.5% of their body weight over 72 weeks. Individual results vary, but the data behind this medication is stronger than anything previously available for non-surgical weight loss.
Both medications are weekly injectables. Both reduce appetite and improve blood sugar regulation. Semaglutide activates one receptor pathway, GLP-1. Tirzepatide activates two, GLP-1 and GIP. That additional pathway produces a stronger metabolic effect for most patients.
ThinMD offers both medications. Dr. Capasso reviews your health history, current weight, metabolic labs, and any prior medication history before recommending one over the other. That determination is made at your consultation, not before it.
Tirzepatide is a prescription medication. You may be a candidate if:
Dr. Capasso makes all prescribing decisions after reviewing your full medical history and labs.
Initial Consultation
Dr. Capasso reviews your health history, metabolic labs, and weight loss history. He determines whether tirzepatide is appropriate, what starting dose makes sense, and what to watch for as your body adjusts.
Dose Titration
Tirzepatide is started at a low dose and increased gradually over several weeks. This reduces the likelihood of gastrointestinal side effects, nausea, which is the most common complaint, is significantly reduced when dosing is done correctly.
Ongoing Monitoring
Dr. Capasso monitors your progress at scheduled follow-up appointments. Dose adjustments are made based on your response and tolerance.
Medication Access
ThinMD works with licensed compounding pharmacies and authorized dispensing channels. You receive your medication through a vetted supply chain, not an unverified online source.
Dr. Capasso is the Medical Director of ThinMD MedSpa. He prescribes and supervises all weight loss medication protocols at this practice. His oversight means your treatment plan is based on your labs and your health history, not a template.
If you are ready to find out whether tirzepatide is the right medication for you, the next step is a consultation at ThinMD MedSpa in Jacksonville Beach.
ThinMD MedSpa, Jacksonville Beach, FL
Led by Dr. Anthony Capasso MD
Tirzepatide activates two receptors, GLP-1 and GIP, while semaglutide activates one (GLP-1 only). Clinical trials comparing the two have shown tirzepatide producing greater average weight loss in head-to-head comparisons. Both are effective; the right choice depends on your health profile, tolerance, and history with either medication. Dr. Capasso reviews your bloodwork and medical history to recommend the appropriate option.
Tirzepatide is FDA-approved under the brand name Zepbound for chronic weight management and Mounjaro for type 2 diabetes. It has been evaluated in large-scale clinical trials. At ThinMD, all prescriptions are supervised by Dr. Anthony Capasso MD, who monitors your progress and adjusts dosing as needed. Common side effects during dose escalation include mild nausea and gastrointestinal adjustment, these typically resolve as your body adapts.
Most patients at our Jacksonville and Jacksonville Beach locations begin noticing appetite changes and early weight response within the first few weeks of the starting dose. Significant body weight changes typically become measurable after the first 8 to 12 weeks. Tirzepatide is dosed in a step-up protocol, your dose increases gradually over several months, which allows your body to adapt and reduces side effects.
Tirzepatide is a tool, not a life sentence. Many patients use it to achieve a target weight and then transition to a maintenance program that may include hormone optimization, nutritional guidance, and metabolic monitoring. Your protocol at ThinMD is reviewed regularly and adjusted based on your goals and response.
ThinMD prescribes FDA-approved tirzepatide through licensed pharmacies. We discuss all available options during your consultation, including the difference between branded and compounded options and current FDA guidance on compounding. Your safety and treatment quality are the priority.
Your first appointment includes a review of your health history, current medications, and weight loss goals, followed by comprehensive bloodwork. Once results are reviewed, Dr. Capasso determines whether tirzepatide is the right fit and what starting dose is appropriate for your situation. There is no pressure to proceed, the consultation is an evaluation, not a sales appointment.
ThinMD MedSpa serves Jacksonville, Jacksonville Beach, and surrounding areas. Call (904) 694-0992 (Jacksonville Beach) or (904) 619-0130 (San Jose) to schedule your tirzepatide consultation.
ThinMD MedSpa serves patients across the greater Jacksonville area from two physician-supervised locations. Same standard of care, same medical team, both fully equipped.
Tirzepatide is a dual GIP and GLP-1 receptor agonist that suppresses appetite, slows gastric emptying, and improves insulin sensitivity through two complementary mechanisms. Clinical trials showed average weight loss of 20 to 22 percent of body weight over 72 weeks, making it one of the most effective pharmaceutical weight loss options available. ThinMD MedSpa prescribes it as part of a supervised program.
Semaglutide activates GLP-1 receptors only. Tirzepatide activates both GLP-1 and GIP receptors, which appear to work synergistically for greater weight loss and metabolic improvement. Head-to-head data shows tirzepatide produces approximately 5 to 8 percent more weight loss on average. ThinMD MedSpa evaluates each patient’s health profile to determine which medication is the better fit.
The most common side effects are gastrointestinal, including nausea, reduced appetite, and occasional vomiting or diarrhea, particularly when starting or increasing the dose. These typically improve as the body adjusts. ThinMD MedSpa uses a gradual dose escalation protocol to minimize side effects and monitors patients throughout their program.
Tirzepatide is approved for adults with a BMI of 27 or higher with at least one weight-related health condition, or a BMI of 30 or higher. It is not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN2. ThinMD MedSpa conducts a full health review and lab work before prescribing.
Tirzepatide is most effective as part of a long-term weight management approach. Patients who stop the medication typically regain a portion of lost weight over time unless significant lifestyle changes have been established. ThinMD MedSpa supports patients in building sustainable habits during treatment and creates a long-term plan for weight maintenance.
Reach us at either Jacksonville location. Our team responds to all inquiries.
